NTRA insider buying and SEC filings, explained
Natera, Inc. · CIK 1604821
Tracked: Forms 3/4/5, 8-K, NT · All filings on sec.gov
Insider activity in the last 12 months
Bought
$0
Insiders who bought
0
Sold (not marked 10b5-1)
$45.9M
Planned sales (10b5-1)
$352.3M
Insider purchases and sales, last 12 months
| Traded | Type | What was filed | Source |
|---|---|---|---|
| Oct 28–30, 2026 | Planned (10b5-1) | Michael Burkes Brophy (CFO) sold 3,084 shares between Oct 28 and Oct 30 at about $425.90 ($1.3M), marked as a 10b5-1 plan trade. Holdings down 6% to 46,574 shares. | SEC filing Filed Oct 30, 2026, 9:35 PM ET |
| Oct 27–28, 2026 | Planned (10b5-1) | Jonathan Sheena (Director and Co-Founder) sold 478 shares between Oct 27 and Oct 28 at about $413.96 ($198K), marked as a 10b5-1 plan trade. Holdings down <1% to 217,686 shares. | SEC filing Filed Oct 29, 2026, 9:35 PM ET |
| Oct 27, 2026 | Planned (10b5-1) | Matthew Rabinowitz (Chair and Director) sold 1,718 shares at $406.00 ($698K), marked as a 10b5-1 plan trade. Holdings down <1% to 2,117,676 shares. | SEC filing Filed Oct 29, 2026, 9:35 PM ET |
| Oct 27–28, 2026 | Planned (10b5-1) | Daniel Rabinowitz (Sec. and Chief Legal Officer) sold 1,852 shares between Oct 27 and Oct 28 at about $416.63 ($772K), marked as a 10b5-1 plan trade. Holdings down 1% to 168,221 shares. | SEC filing Filed Oct 29, 2026, 9:35 PM ET |
| Oct 27–28, 2026 | Planned (10b5-1) | Solomon Moshkevich (President / COO) sold 2,172 shares between Oct 27 and Oct 28 at about $416.88 ($905K), marked as a 10b5-1 plan trade. Holdings down 2% to 104,742 shares. | SEC filing Filed Oct 29, 2026, 9:35 PM ET |
| Oct 27–28, 2026 | Planned (10b5-1) | John Fesko (President / COO) sold 1,679 shares between Oct 27 and Oct 28 at about $416.88 ($700K), marked as a 10b5-1 plan trade. Holdings down 1% to 195,578 shares. | SEC filing Filed Oct 29, 2026, 9:35 PM ET |
| Oct 27–28, 2026 | Planned (10b5-1) | Steven Leonard Chapman (CEO and Director) sold 5,694 shares between Oct 27 and Oct 28 at about $418.25 ($2.4M), marked as a 10b5-1 plan trade. Holdings down 6% to 91,232 shares. | SEC filing Filed Oct 29, 2026, 9:35 PM ET |
| Oct 27–28, 2026 | Planned (10b5-1) | Michael Burkes Brophy (CFO) sold 1,979 shares between Oct 27 and Oct 28 at about $418.31 ($828K), marked as a 10b5-1 plan trade. Holdings down 4% to 49,658 shares. | SEC filing Filed Oct 29, 2026, 9:35 PM ET |
| Oct 21, 2026 | Planned (10b5-1) | Jonathan Sheena (Director and Co-Founder) sold 3,150 shares at about $410.55 ($1.3M), marked as a 10b5-1 plan trade. Holdings down 1% to 218,164 shares. | SEC filing Filed Oct 23, 2026, 9:25 PM ET |
| Oct 16, 2026 | Planned (10b5-1) | Jonathan Sheena (Director and Co-Founder) sold 1,500 shares indirectly (by trust) at about $402.47 ($604K), marked as a 10b5-1 plan trade. Holdings by trust down 8% to 8,250 shares. | SEC filing Filed Oct 20, 2026, 9:35 PM ET |
| Oct 15, 2026 | Planned (10b5-1) | Matthew Rabinowitz (Chair and Director) sold 50,000 shares at about $402.64 ($20.1M), marked as a 10b5-1 plan trade. Holdings down 2% to 2,119,394 shares. | SEC filing Filed Oct 16, 2026, 9:35 PM ET |
| Oct 1, 2026 | Planned (10b5-1) | Steven Leonard Chapman (CEO and Director) sold 1,273 shares at $413.31 ($526K), marked as a 10b5-1 plan trade. Holdings down 1% to 96,926 shares. | SEC filing Filed Oct 2, 2026, 9:35 PM ET |
| Oct 1, 2026 | Planned (10b5-1) | Solomon Moshkevich (President / COO) sold 3,000 shares at about $414.22 ($1.2M), marked as a 10b5-1 plan trade. Holdings down 3% to 106,914 shares. | SEC filing Filed Oct 2, 2026, 9:35 PM ET |
| Sep 23, 2026 | Planned (10b5-1) | Jonathan Sheena (Director and Co-Founder) sold 18,064 shares indirectly (by trust) at about $388.01 ($7.0M), marked as a 10b5-1 plan trade. Holdings by trust down 50% to 9,000 shares. | SEC filing Filed Sep 25, 2026 |
| Sep 15–16, 2026 | Planned (10b5-1) | Jonathan Sheena (Director and Co-Founder) sold 9,150 shares between Sep 15 and Sep 16 at about $351.49 ($3.2M), marked as a 10b5-1 plan trade. Holdings down 4% to 221,314 shares. | SEC filing Filed Sep 17, 2026 |
| Sep 14–15, 2026 | Planned (10b5-1) | Matthew Rabinowitz (Chair and Director) sold 102,000 shares directly and indirectly (by spouse) between Sep 14 and Sep 15 at about $341.15 ($34.8M), marked as a 10b5-1 plan trade. Direct holdings down 4% to 2,125,394 shares. | SEC filing Filed Sep 16, 2026 |
| Sep 11, 2026 | Planned (10b5-1) | Matthew Rabinowitz (Chair and Director) sold 50,000 shares at about $327.96 ($16.4M), marked as a 10b5-1 plan trade. Holdings down 2% to 2,225,394 shares. | SEC filing Filed Sep 11, 2026 |
| Sep 1–2, 2026 | Planned (10b5-1) | Solomon Moshkevich (President / COO) sold 18,160 shares between Sep 1 and Sep 2 at about $325.87 ($5.9M), marked as a 10b5-1 plan trade. Holdings down 14% to 110,859 shares. | SEC filing Filed Sep 3, 2026 |
| Sep 1, 2026 | Planned (10b5-1) | Steven Leonard Chapman (CEO and Director) sold 1,698 shares at $320.99 ($545K), marked as a 10b5-1 plan trade. Holdings down 2% to 98,199 shares. | SEC filing Filed Sep 3, 2026 |
| Aug 10, 2026 | Planned (10b5-1) | John Fesko (President / COO) sold 6,517 shares at $321.53 ($2.1M), marked as a 10b5-1 plan trade. Holdings down 3% to 197,257 shares. | SEC filing Filed Aug 28, 2026 |
| Aug 10, 2026 | Planned (10b5-1) | Jonathan Sheena (Director and Co-Founder) sold 6,000 shares at about $325.32 ($2.0M), marked as a 10b5-1 plan trade. Holdings down 3% to 230,464 shares. | SEC filing Filed Aug 14, 2026 |
| Aug 7, 2026 | Planned (10b5-1) | Jonathan Sheena (Director and Co-Founder) sold 9,150 shares at about $315.66 ($2.9M), marked as a 10b5-1 plan trade. Holdings down 4% to 236,464 shares. | SEC filing Filed Aug 7, 2026 |
| Aug 7, 2026 | Planned (10b5-1) | Matthew Rabinowitz (Chair and Director) sold 2,000 shares indirectly (by spouse) at $320.90 ($642K), marked as a 10b5-1 plan trade. Holdings by spouse down 50% to 2,000 shares. | SEC filing Filed Aug 7, 2026 |
| Aug 3, 2026 | Planned (10b5-1) | John Fesko (President / COO) sold 295 shares at $267.99 ($79K), marked as a 10b5-1 plan trade. Holdings down <1% to 183,774 shares. | SEC filing Filed Aug 5, 2026 |
| Aug 3, 2026 | Planned (10b5-1) | Solomon Moshkevich (President / COO) sold 3,410 shares at about $265.58 ($906K), marked as a 10b5-1 plan trade. Holdings down 3% to 129,019 shares. | SEC filing Filed Aug 5, 2026 |
| Aug 3, 2026 | Planned (10b5-1) | Daniel Rabinowitz (Sec. and Chief Legal Officer) sold 334 shares at $267.99 ($90K), marked as a 10b5-1 plan trade. Holdings down <1% to 170,073 shares. | SEC filing Filed Aug 5, 2026 |
| Aug 3, 2026 | Planned (10b5-1) | Steven Leonard Chapman (CEO and Director) sold 3,076 shares at about $266.39 ($819K), marked as a 10b5-1 plan trade. Holdings down 3% to 99,897 shares. | SEC filing Filed Aug 5, 2026 |
| Aug 3–4, 2026 | Planned (10b5-1) | Michael Burkes Brophy (CFO) sold 795 shares between Aug 3 and Aug 4 at about $271.74 ($216K), marked as a 10b5-1 plan trade. Holdings down 2% to 51,637 shares. | SEC filing Filed Aug 5, 2026 |
| Aug 3, 2026 | Planned (10b5-1) | Jonathan Sheena (Director and Co-Founder) sold 109 shares at $267.99 ($29K), marked as a 10b5-1 plan trade. Holdings down <1% to 245,614 shares. | SEC filing Filed Aug 5, 2026 |
| Aug 3, 2026 | Planned (10b5-1) | Matthew Rabinowitz (Chair and Director) sold 731 shares at $267.99 ($196K), marked as a 10b5-1 plan trade. Holdings down <1% to 2,275,394 shares. | SEC filing Filed Aug 5, 2026 |
| Jul 27–28, 2026 | Planned (10b5-1) | John Fesko (President / COO) sold 1,713 shares between Jul 27 and Jul 28 at about $257.00 ($440K), marked as a 10b5-1 plan trade. Holdings down 1% to 184,069 shares. | SEC filing Filed Jul 29, 2026 |
| Jul 27–28, 2026 | Planned (10b5-1) | Solomon Moshkevich (President / COO) sold 2,214 shares between Jul 27 and Jul 28 at about $257.00 ($569K), marked as a 10b5-1 plan trade. Holdings down 2% to 132,429 shares. | SEC filing Filed Jul 29, 2026 |
| Jul 27–28, 2026 | Planned (10b5-1) | Daniel Rabinowitz (Sec. and Chief Legal Officer) sold 1,887 shares between Jul 27 and Jul 28 at about $257.08 ($485K), marked as a 10b5-1 plan trade. Holdings down 1% to 170,407 shares. | SEC filing Filed Jul 29, 2026 |
| Jul 27–28, 2026 | Planned (10b5-1) | Steven Leonard Chapman (CEO and Director) sold 5,770 shares between Jul 27 and Jul 28 at about $256.51 ($1.5M), marked as a 10b5-1 plan trade. Holdings down 5% to 102,973 shares. | SEC filing Filed Jul 29, 2026 |
| Jul 27–29, 2026 | Planned (10b5-1) | Michael Burkes Brophy (CFO) sold 5,064 shares between Jul 27 and Jul 29 at about $253.29 ($1.3M), marked as a 10b5-1 plan trade. Holdings down 9% to 52,432 shares. | SEC filing Filed Jul 29, 2026 |
| Jul 27–28, 2026 | Planned (10b5-1) | Jonathan Sheena (Director and Co-Founder) sold 479 shares between Jul 27 and Jul 28 at about $257.93 ($124K), marked as a 10b5-1 plan trade. Holdings down <1% to 245,723 shares. | SEC filing Filed Jul 29, 2026 |
| Jul 27, 2026 | Planned (10b5-1) | Matthew Rabinowitz (Chair and Director) sold 1,718 shares at $260.49 ($448K), marked as a 10b5-1 plan trade. Holdings down <1% to 2,276,125 shares. | SEC filing Filed Jul 29, 2026 |
| Jul 15, 2026 | Planned (10b5-1) | Rowan E Chapman (Director) sold 135 shares at $274.82 ($37K), marked as a 10b5-1 plan trade. Holdings down 3% to 4,663 shares. | SEC filing Filed Jul 17, 2026 |
| Jul 15, 2026 | Planned (10b5-1) | Jonathan Sheena (Director and Co-Founder) sold 1,500 shares indirectly (by trust) at about $273.88 ($411K), marked as a 10b5-1 plan trade. Holdings by trust down 4% to 18,032 shares. | SEC filing Filed Jul 17, 2026 |
| Jul 13, 2026 | Planned (10b5-1) | Jonathan Sheena (Director and Co-Founder) sold 3,150 shares at about $265.68 ($837K), marked as a 10b5-1 plan trade. Holdings down 1% to 246,202 shares. | SEC filing Filed Jul 15, 2026 |
| Jul 6, 2026 | Planned (10b5-1) | Matthew Rabinowitz (Chair and Director) sold 1,000 shares indirectly (by spouse) at $280.00 ($280K), marked as a 10b5-1 plan trade. Holdings by spouse down 20% to 4,000 shares. | SEC filing Filed Jul 8, 2026 |
| Jul 1, 2026 | Planned (10b5-1) | Solomon Moshkevich (President / COO) sold 3,000 shares at about $272.90 ($819K), marked as a 10b5-1 plan trade. Holdings down 2% to 134,643 shares. | SEC filing Filed Jul 6, 2026 |
| Jul 1, 2026 | Planned (10b5-1) | Daniel Rabinowitz (Sec. and Chief Legal Officer) sold 16,800 shares at about $272.29 ($4.6M), marked as a 10b5-1 plan trade. Holdings down 9% to 172,294 shares. | SEC filing Filed Jul 6, 2026 |
| Jun 24, 2026 | Planned (10b5-1) | Daniel Rabinowitz (Sec. and Chief Legal Officer) sold 33,600 shares at about $251.65 ($8.5M), marked as a 10b5-1 plan trade. Holdings down 15% to 189,094 shares. | SEC filing Filed Jun 26, 2026 |
| Jun 24, 2026 | Planned (10b5-1) | Herm Rosenman (Director) sold 16,530 shares at $250.00 ($4.1M), marked as a 10b5-1 plan trade. Holdings down 80% to 4,250 shares. | SEC filing Filed Jun 26, 2026 |
| Jun 17, 2026 | Planned (10b5-1) | Jonathan Sheena (Director and Co-Founder) sold 1,500 shares indirectly (by trust) at about $219.88 ($330K), marked as a 10b5-1 plan trade. Holdings by trust down 4% to 18,782 shares. | SEC filing Filed Jun 22, 2026 |
| Jun 16, 2026 | Planned (10b5-1) | Rowan E Chapman (Director) sold 2,964 shares at $216.78 ($643K), marked as a 10b5-1 plan trade. Holdings down 49% to 3,124 shares. | SEC filing Filed Jun 17, 2026 |
| Jun 15, 2026 | Planned (10b5-1) | Jonathan Sheena (Director and Co-Founder) sold 3,150 shares at about $211.14 ($665K), marked as a 10b5-1 plan trade. Holdings down 1% to 249,352 shares. | SEC filing Filed Jun 17, 2026 |
| Jun 12–15, 2026 | Planned (10b5-1) | Matthew Rabinowitz (Chair and Director) sold 100,000 shares between Jun 12 and Jun 15 at about $214.47 ($21.4M), marked as a 10b5-1 plan trade. Holdings down 4% to 2,277,843 shares. | SEC filing Filed Jun 16, 2026 |
| Jun 4, 2026 | Planned (10b5-1) | Steven Leonard Chapman (CEO and Director) sold 41,124 shares at about $221.03 ($9.1M), marked as a 10b5-1 plan trade. Holdings down 27% to 108,743 shares. | SEC filing Filed Jun 5, 2026 |
| Jun 1, 2026 | Planned (10b5-1) | Solomon Moshkevich (President / COO) sold 3,000 shares at about $218.43 ($655K), marked as a 10b5-1 plan trade. Holdings down 2% to 137,643 shares. | SEC filing Filed Jun 3, 2026 |
| Jun 1, 2026 | Sale | Roelof Botha (Director) sold 78,000 shares indirectly at about $220.31 ($17.2M). Indirect holdings down 7% to 1,076,198 shares. Not marked as a 10b5-1 plan trade. | SEC filing Filed Jun 3, 2026 |
| May 26, 2026 | Planned (10b5-1) | John Fesko (President / COO) sold 1,438 shares at $202.84 ($292K), marked as a 10b5-1 plan trade. Holdings down 1% to 185,782 shares. | SEC filing Filed May 28, 2026 |
| May 26, 2026 | Planned (10b5-1) | Solomon Moshkevich (President / COO) sold 1,652 shares at $202.84 ($335K), marked as a 10b5-1 plan trade. Holdings down 1% to 140,643 shares. | SEC filing Filed May 28, 2026 |
| May 8–13, 2026 | Planned (10b5-1) | Jonathan Sheena (Director and Co-Founder) sold 4,650 shares directly and indirectly (by trust) between May 8 and May 13 at about $206.33 ($959K), marked as a 10b5-1 plan trade. Direct holdings down 1% to 252,502 shares. | SEC filing Filed May 15, 2026 |
| May 4–5, 2026 | Planned (10b5-1) | Matthew Rabinowitz (Chair and Director) sold 7,708 shares between May 4 and May 5 at about $213.05 ($1.6M), marked as a 10b5-1 plan trade. Holdings down <1% to 2,377,843 shares. | SEC filing Filed May 6, 2026 |
| May 1, 2026 | Planned (10b5-1) | John Fesko (President / COO) sold 291 shares at $206.16 ($60K), marked as a 10b5-1 plan trade. Holdings down <1% to 187,220 shares. | SEC filing Filed May 5, 2026 |
| May 1, 2026 | Planned (10b5-1) | Solomon Moshkevich (President / COO) sold 3,405 shares at about $203.69 ($694K), marked as a 10b5-1 plan trade. Holdings down 2% to 142,295 shares. | SEC filing Filed May 5, 2026 |
| May 1, 2026 | Planned (10b5-1) | Daniel Rabinowitz (Sec. and Chief Legal Officer) sold 330 shares at $206.16 ($68K), marked as a 10b5-1 plan trade. Holdings down <1% to 222,694 shares. | SEC filing Filed May 5, 2026 |
| May 1, 2026 | Planned (10b5-1) | Steven Leonard Chapman (CEO and Director) sold 902 shares at $206.16 ($186K), marked as a 10b5-1 plan trade. Holdings down 1% to 149,867 shares. | SEC filing Filed May 5, 2026 |
| May 1–4, 2026 | Planned (10b5-1) | Michael Burkes Brophy (CFO) sold 795 shares between May 1 and May 4 at about $208.79 ($166K), marked as a 10b5-1 plan trade. Holdings down 1% to 57,496 shares. | SEC filing Filed May 5, 2026 |
| May 1, 2026 | Planned (10b5-1) | Jonathan Sheena (Director and Co-Founder) sold 107 shares at $206.16 ($22K), marked as a 10b5-1 plan trade. Holdings down <1% to 255,652 shares. | SEC filing Filed May 5, 2026 |
| Apr 27, 2026 | Planned (10b5-1) | John Fesko (President / COO) sold 1,688 shares at about $204.10 ($345K), marked as a 10b5-1 plan trade. Holdings down 1% to 187,511 shares. | SEC filing Filed Apr 29, 2026 |
| Apr 27, 2026 | Planned (10b5-1) | Solomon Moshkevich (President / COO) sold 2,182 shares at about $204.10 ($445K), marked as a 10b5-1 plan trade. Holdings down 1% to 145,700 shares. | SEC filing Filed Apr 29, 2026 |
| Apr 27, 2026 | Planned (10b5-1) | Daniel Rabinowitz (Sec. and Chief Legal Officer) sold 1,861 shares at about $204.09 ($380K), marked as a 10b5-1 plan trade. Holdings down 1% to 223,024 shares. | SEC filing Filed Apr 29, 2026 |
| Apr 27, 2026 | Planned (10b5-1) | Steven Leonard Chapman (CEO and Director) sold 5,838 shares at about $204.14 ($1.2M), marked as a 10b5-1 plan trade. Holdings down 4% to 150,769 shares. | SEC filing Filed Apr 29, 2026 |
| Apr 27–29, 2026 | Planned (10b5-1) | Michael Burkes Brophy (CFO) sold 5,063 shares between Apr 27 and Apr 29 at about $197.84 ($1.0M), marked as a 10b5-1 plan trade. Holdings down 8% to 58,291 shares. | SEC filing Filed Apr 29, 2026 |
| Apr 27–29, 2026 | Planned (10b5-1) | Jonathan Sheena (Director and Co-Founder) sold 3,544 shares between Apr 27 and Apr 29 at about $197.43 ($700K), marked as a 10b5-1 plan trade. Holdings down 1% to 255,711 shares. | SEC filing Filed Apr 29, 2026 |
| Apr 17, 2026 | Planned (10b5-1) | Jonathan Sheena (Director and Co-Founder) sold 1,500 shares indirectly (by trust) at about $199.63 ($299K), marked as a 10b5-1 plan trade. Holdings by trust down 4% to 20,282 shares. | SEC filing Filed Apr 21, 2026 |
| Apr 1, 2026 | Planned (10b5-1) | Solomon Moshkevich (President / COO) sold 3,000 shares at about $202.30 ($607K), marked as a 10b5-1 plan trade. Holdings down 2% to 147,882 shares. | SEC filing Filed Apr 3, 2026 |
| Apr 1, 2026 | Planned (10b5-1) | Daniel Rabinowitz (Sec. and Chief Legal Officer) sold 8,400 shares at about $203.31 ($1.7M), marked as a 10b5-1 plan trade. Holdings down 4% to 224,885 shares. | SEC filing Filed Apr 3, 2026 |
| Mar 18–20, 2026 | Planned (10b5-1) | Jonathan Sheena (Director and Co-Founder) sold 4,570 shares directly and indirectly (by trust) between Mar 18 and Mar 20 at about $198.75 ($908K), marked as a 10b5-1 plan trade. Direct holdings down 1% to 259,255 shares. | SEC filing Filed Mar 20, 2026 |
| Mar 13, 2026 | Planned (10b5-1) | Rowan E Chapman (Director) sold 122 shares at $191.38 ($23K), marked as a 10b5-1 plan trade. Holdings down 2% to 5,752 shares. | SEC filing Filed Mar 17, 2026 |
| Mar 12–16, 2026 | Planned (10b5-1) | Matthew Rabinowitz (Chair and Director) sold 200,000 shares between Mar 12 and Mar 16 at about $191.42 ($38.3M), marked as a 10b5-1 plan trade. Holdings down 8% to 2,310,772 shares. | SEC filing Filed Mar 16, 2026 |
| Mar 10, 2026 | Planned (10b5-1) | John Fesko (President / COO) sold 707 shares at $204.13 ($144K), marked as a 10b5-1 plan trade. Holdings down <1% to 189,199 shares. | SEC filing Filed Mar 11, 2026 |
| Mar 10, 2026 | Planned (10b5-1) | Solomon Moshkevich (President / COO) sold 915 shares at $204.13 ($187K), marked as a 10b5-1 plan trade. Holdings down 1% to 150,882 shares. | SEC filing Filed Mar 11, 2026 |
| Mar 10, 2026 | Planned (10b5-1) | Daniel Rabinowitz (Sec. and Chief Legal Officer) sold 1,745 shares at $204.13 ($356K), marked as a 10b5-1 plan trade. Holdings down 1% to 233,285 shares. | SEC filing Filed Mar 11, 2026 |
| Mar 10, 2026 | Planned (10b5-1) | Steven Leonard Chapman (CEO and Director) sold 5,623 shares at $204.13 ($1.1M), marked as a 10b5-1 plan trade. Holdings down 3% to 156,607 shares. | SEC filing Filed Mar 11, 2026 |
| Mar 10, 2026 | Planned (10b5-1) | Michael Burkes Brophy (CFO) sold 785 shares at $204.13 ($160K), marked as a 10b5-1 plan trade. Holdings down 1% to 63,354 shares. | SEC filing Filed Mar 11, 2026 |
| Mar 10, 2026 | Planned (10b5-1) | Jonathan Sheena (Director and Co-Founder) sold 127 shares at $204.13 ($26K), marked as a 10b5-1 plan trade. Holdings down <1% to 262,325 shares. | SEC filing Filed Mar 11, 2026 |
| Mar 6, 2026 | Planned (10b5-1) | Daniel Rabinowitz (Sec. and Chief Legal Officer) sold 8,398 shares at about $196.08 ($1.6M), marked as a 10b5-1 plan trade. Holdings down 3% to 233,285 shares. | SEC filing Filed Mar 10, 2026 |
| Mar 2, 2026 | Planned (10b5-1) | Solomon Moshkevich (President / COO) sold 3,000 shares at about $199.85 ($600K), marked as a 10b5-1 plan trade. Holdings down 2% to 150,023 shares. | SEC filing Filed Mar 3, 2026 |
| Mar 2, 2026 | Planned (10b5-1) | Steven Leonard Chapman (CEO and Director) sold 3,950 shares at about $200.02 ($790K), marked as a 10b5-1 plan trade. Holdings down 2% to 156,607 shares. | SEC filing Filed Mar 3, 2026 |
| Mar 2, 2026 | Planned (10b5-1) | Jonathan Sheena (Director and Co-Founder) sold 3,070 shares at about $200.23 ($615K), marked as a 10b5-1 plan trade. Holdings down 1% to 262,194 shares. | SEC filing Filed Mar 3, 2026 |
| Feb 3, 2026 | Planned (10b5-1) | John Fesko (President / COO) sold 3,594 shares at about $231.02 ($830K), marked as a 10b5-1 plan trade. Holdings down 2% to 178,081 shares. | SEC filing Filed Feb 4, 2026 |
| Feb 3, 2026 | Planned (10b5-1) | Daniel Rabinowitz (Sec. and Chief Legal Officer) sold 1,334 shares at $230.77 ($308K), marked as a 10b5-1 plan trade. Holdings down 1% to 223,813 shares. | SEC filing Filed Feb 4, 2026 |
| Feb 3, 2026 | Planned (10b5-1) | Michael Burkes Brophy (CFO) sold 6,939 shares at about $227.83 ($1.6M), marked as a 10b5-1 plan trade. Holdings down 12% to 52,120 shares. | SEC filing Filed Feb 4, 2026 |
| Feb 3, 2026 | Planned (10b5-1) | Jonathan Sheena (Director and Co-Founder) sold 435 shares at $230.77 ($100K), marked as a 10b5-1 plan trade. Holdings down <1% to 263,161 shares. | SEC filing Filed Feb 4, 2026 |
| Feb 2–3, 2026 | Planned (10b5-1) | Solomon Moshkevich (President / COO) sold 4,639 shares between Feb 2 and Feb 3 at about $231.20 ($1.1M), marked as a 10b5-1 plan trade. Holdings down 3% to 137,847 shares. | SEC filing Filed Feb 4, 2026 |
| Feb 2–3, 2026 | Planned (10b5-1) | Steven Leonard Chapman (CEO and Director) sold 90,024 shares between Feb 2 and Feb 3 at about $230.72 ($20.8M), marked as a 10b5-1 plan trade. Holdings down 42% to 123,156 shares. | SEC filing Filed Feb 4, 2026 |
| Jan 27–28, 2026 | Planned (10b5-1) | John Fesko (President / COO) sold 1,712 shares between Jan 27 and Jan 28 at about $238.97 ($409K), marked as a 10b5-1 plan trade. Holdings down 1% to 175,540 shares. | SEC filing Filed Jan 29, 2026 |
| Jan 27–28, 2026 | Planned (10b5-1) | Solomon Moshkevich (President / COO) sold 2,213 shares between Jan 27 and Jan 28 at about $238.97 ($529K), marked as a 10b5-1 plan trade. Holdings down 2% to 142,486 shares. | SEC filing Filed Jan 29, 2026 |
| Jan 27–28, 2026 | Planned (10b5-1) | Daniel Rabinowitz (Sec. and Chief Legal Officer) sold 1,886 shares between Jan 27 and Jan 28 at about $239.01 ($451K), marked as a 10b5-1 plan trade. Holdings down 1% to 225,147 shares. | SEC filing Filed Jan 29, 2026 |
| Jan 27–28, 2026 | Planned (10b5-1) | Steven Leonard Chapman (CEO and Director) sold 5,970 shares between Jan 27 and Jan 28 at about $238.78 ($1.4M), marked as a 10b5-1 plan trade. Holdings down 3% to 213,180 shares. | SEC filing Filed Jan 29, 2026 |
| Jan 27–29, 2026 | Planned (10b5-1) | Michael Burkes Brophy (CFO) sold 5,064 shares between Jan 27 and Jan 29 at about $235.38 ($1.2M), marked as a 10b5-1 plan trade. Holdings down 8% to 59,059 shares. | SEC filing Filed Jan 29, 2026 |
| Jan 27–28, 2026 | Planned (10b5-1) | Jonathan Sheena (Director and Co-Founder) sold 482 shares between Jan 27 and Jan 28 at about $239.39 ($115K), marked as a 10b5-1 plan trade. Holdings down <1% to 263,596 shares. | SEC filing Filed Jan 29, 2026 |
| Jan 23, 2026 | Planned (10b5-1) | Jonathan Sheena (Director and Co-Founder) sold 1,500 shares indirectly (by trust) at about $243.94 ($366K), marked as a 10b5-1 plan trade. Holdings by trust down 3% to 21,782 shares. | SEC filing Filed Jan 27, 2026 |
| Jan 20–21, 2026 | Planned (10b5-1) | John Fesko (President / COO) sold 18,145 shares between Jan 20 and Jan 21 at about $234.74 ($4.3M), marked as a 10b5-1 plan trade. Holdings down 9% to 177,252 shares. | SEC filing Filed Jan 22, 2026 |
| Jan 20–21, 2026 | Planned (10b5-1) | Solomon Moshkevich (President / COO) sold 23,498 shares between Jan 20 and Jan 21 at about $234.74 ($5.5M), marked as a 10b5-1 plan trade. Holdings down 14% to 144,699 shares. | SEC filing Filed Jan 22, 2026 |
| Jan 20–21, 2026 | Planned (10b5-1) | Daniel Rabinowitz (Sec. and Chief Legal Officer) sold 19,672 shares between Jan 20 and Jan 21 at about $234.75 ($4.6M), marked as a 10b5-1 plan trade. Holdings down 8% to 227,033 shares. | SEC filing Filed Jan 22, 2026 |
Showing the latest 100 transactions.
76 routine transactions (such as grants, option exercises or tax withholding) are not listed.
Cluster buys
No cluster buys in the last 12 months.
Red flags
No red flags in the last 12 months.
Key events
No key events in the last 12 months.
8-K filings, last 12 months
No 8-K filings in the last 12 months.
Red flags are objective triggers only: the item or form filed, never an opinion.
Follow NTRA in the Insider Ledger app
Get the appA plain-English brief of insider purchases, 8-Ks and red flags at the companies you pick. No account needed.